Skip to content

Children With Surgically Corrected Acyanotic Congenital Heart Disease

Children With Surgically Corrected Acyanotic Congenital Heart Disease

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07605832
Acronym
Pediatrics
Enrollment
80
Registered
2026-05-26
Start date
2026-05-31
Completion date
2026-09-01
Last updated
2026-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acyanotic Congenital Heart Disease

Brief summary

The goal of this quasi-experimental pretest-posttest controlled study is to learn whether moderate-intensity treadmill exercise can improve gait kinematics, walking capacity, and motor performance in preschool children aged 48-72 months with surgically corrected acyanotic congenital heart disease. The main questions it aims to answer are: Does moderate-intensity treadmill training improve gait kinematics, including stride length, walking speed, and double-stance percentage? Does moderate-intensity treadmill training improve walking capacity and balance in children with surgically corrected acyanotic congenital heart disease? Researchers compared children with surgically corrected acyanotic congenital heart disease who received treadmill training with age-matched healthy children to see whether the exercise program could reduce gait, balance, and walking-capacity differences between the groups. Participants with congenital heart disease completed: Four treadmill walking sessions per week for 10 weeks. Moderate-intensity walking at approximately 70% of maximal heart rate. Pre- and post-intervention assessments of gait kinematics using three-dimensional motion analysis. Balance assessment using the Pediatric Balance Scale. Walking capacity assessment using the six-minute walk test.

Interventions

OTHERtreadmill walking sessions

4 sessions of walking on treadmill for 2.5 months

Sponsors

Delta University for Science and Technology
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
48 Months to 72 Months
Healthy volunteers
No

Inclusion criteria

* For cyanotic postoperative congenital heart disease group: 1. Children diagnosed with acyanotic postoperative congenital heart disease. 2. Underwent surgical repair for CHD. 3. Has a history of only one surgical intervention. 4. Age between 48 and 72 months. 5. Mentally normal, with an IQ between 85 and 115. For the healthy control group (HCG): * For healthy children aged 48 to 72 months. Full school attendance. Full participation in social and recreational activities. Parents/guardians provided written informed consent.

Exclusion criteria

Children were excluded if they had: 1. Genetic disorders. 2. Severe neurological disorders. 3. Cyanotic congenital heart disease. 4. Perinatal complications.

Design outcomes

Primary

MeasureTime frameDescription
gait parametersbasiline pre-test assessment and after 10 weeks of interventions (post-intervention assessment)Gait parameters, including stride length (cm), speed (meters/minute), and double stance percentage (%) of the dominant leg, were assessed using a 3D motion analysis system.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 27, 2026